Answer
Aug 27, 2025 - 09:11 AM
Maprotiline, an antidepressant, was discontinued in some markets primarily due to declining use and the availability of newer antidepressants with improved safety profiles and fewer side effects. Additionally, concerns about potential side effects, such as seizures, may have contributed to its reduced prescription and eventual discontinuation. It's important to note that discontinuation can vary by country and manufacturer.
